Caldwell Sutter Capital’s Spruce Biosciences SPRB Stock Holding History

Caldwell Sutter Capital’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$702	Hold	13	–	–	﹤0.01%	877
2026 Q1	$850	Hold	13	–	–	﹤0.01%	826
2025 Q4	$1.13K	Hold	13	–	–	﹤0.01%	796
2025 Q3	$116	Hold	13	–	–	﹤0.01%	849
2025 Q2	$73	Hold	13	–	–	﹤0.01%	836
2025 Q1	$290	Hold	13	–	–	﹤0.01%	848
2024 Q4	$420	Hold	13	–	–	﹤0.01%	854
2024 Q3	$475	Hold	13	–	–	﹤0.01%	857
2024 Q2	$518	Hold	13	–	–	﹤0.01%	864
2024 Q1	$786	Hold	13	–	–	﹤0.01%	837
2023 Q4	$2.93K	Hold	13	–	–	﹤0.01%	704
2023 Q3	$2.26K	Hold	13	–	–	﹤0.01%	714
2023 Q2	$2.15K	Buy	+13	New	+$2.17K	﹤0.01%	735

Other funds holding SPRB

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Caldwell Sutter Capital's SPRB Position: Q2 2026 in Review

Caldwell Sutter Capital held its Spruce Biosciences (SPRB) position steady in Q2 2026 at 13 shares worth $702. The position accounts for ﹤0.01% of the portfolio, ranked #877.

Caldwell Sutter Capital first reported a position in SPRB in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.93K in Q4 2023. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

Caldwell Sutter Capital held 13 shares of Spruce Biosciences worth $702 as of Q2 2026.
Caldwell Sutter Capital left its Spruce Biosciences share count unchanged in Q2 2026.
Spruce Biosciences made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #877 holding.
Caldwell Sutter Capital first reported a position in Spruce Biosciences in Q2 2023 and has held it in 13 quarters since.
Caldwell Sutter Capital's Spruce Biosciences position peaked at $2.93K in Q4 2023.
57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.